CURAGEN CORP (CRGN) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 69 transactions totaling $1.4M, demonstrating a bearish sentiment with -$941.4K in net insider flow. The most recent transaction on Oct 1, 2009 involved a transaction of 55,000 shares valued at $0.
No significant insider buying has been recorded for CRGN in the recent period.
No significant insider selling has been recorded for CRGN in the recent period.
Based on recent SEC filings, insider sentiment for CRGN is bearish with an Insider Alignment Score of 16/100 and a net flow of -$941.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CURAGEN CORP (CRGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading CRGN stock, having executed 69 transactions in the past 90 days. The most active insider is Jonathan M. Rothberg (Executive), who has made 19 transactions totaling $835.2K.
Get notified when executives and directors at CRGN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 1, 2009 | H. Forsgren John | Executive | Disposition | 55,000 | $N/A | $0 | |
| Oct 1, 2009 | Noble James | Executive | Disposition | 20,000 | $N/A | $0 | |
| Oct 1, 2009 | E. Patricelli Robert | Executive | Disposition | 364,650 | $N/A | $0 | |
| Oct 1, 2009 | J. Zenner Patrick | Executive | Disposition | 10,000 | $N/A | $0 | |
| Oct 1, 2009 | A. Cassidy Sean | Executive | Disposition | 50,000 | $N/A | $0 | |
| Oct 1, 2009 | M. Finigan Paul | Executive | Disposition | 75,000 | $N/A | $0 | |
| Oct 1, 2009 | M. Shannon Timothy | Executive | Disposition | 241,740 | $N/A | $0 | |
| Oct 1, 2009 | Devita Vincent | Executive | Disposition | 30,000 | $N/A | $0 | |
| Oct 1, 2009 | H. Forsgren John | Executive | Disposition | 55,000 | $N/A | $0 | |
| Oct 1, 2009 | E. Patricelli Robert | Executive | Disposition | 364,650 | $N/A | $0 | |
| Oct 1, 2009 | J. Zenner Patrick | Executive | Disposition | 10,000 | $N/A | $0 | |
| Oct 1, 2009 | A. Cassidy Sean | Executive | Disposition | 50,000 | $N/A | $0 | |
| Oct 1, 2009 | M. Finigan Paul | Executive | Disposition | 75,000 | $N/A | $0 | |
| Oct 1, 2009 | M. Shannon Timothy | Executive | Disposition | 241,740 | $N/A | $0 | |
| Oct 1, 2009 | Devita Vincent | Executive | Disposition | 30,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 33 | $1.2M | 80.0% |
Purchase(P) | 6 | $213.3K | 14.8% |
Exercise(M) | 1 | $74.8K | 5.2% |
Disposition(D) | 16 | $0 | 0.0% |
Award(A) | 13 | $0 | 0.0% |
Insider selling pressure at CURAGEN CORP has increased, with 12 insiders executing 69 transactions across all time. Total sales of $1.2M significantly outpace purchases of $213.3K, resulting in a net outflow of $941.4K. This selling activity appears largely discretionary, which may warrant closer attention from investors.